NCT03423342View on ClinicalTrials.gov

Nicotinamide Riboside in Systolic Heart Failure

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 19, 2016

Primary Completion Date

April 11, 2019

Study Completion Date

June 30, 2019

Conditions
Heart Failure, Systolic
Interventions
DIETARY_SUPPLEMENT

nicotinamide riboside

nicotinamide riboside capsule

DRUG

Placebo

matching placebo capsule

Trial Locations (1)

98195

University of Washington, Seattle

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Washington

OTHER

NCT03423342 - Nicotinamide Riboside in Systolic Heart Failure | Biotech Hunter | Biotech Hunter